Creatine Through Menopause and Evidence for Muscle and Bone
By Isabelle Statovci | Monthly Blog Contributor, Jenerise | Accredited Practising Dietitian & Clinical and Exercise Scientist
The menopausal transition fundamentally alters musculoskeletal physiology, closely intertwined with the broader process of midlife aging rather than serving as a solitary endocrine event. While declining estrogen levels shift bone metabolism toward resorption and degrade muscle quality, the loss of skeletal muscle mass occurs gradually and is multifactorial. Hormone therapy alone appears to have limited and inconsistent effects on muscle mass, making targeted behavioral interventions essential. While progressive resistance training and high protein intake are the foundational, non-negotiable therapies to counteract anabolic resistance, creatine monohydrate has emerged as an effective, evidence-based adjunct for supporting strength and cellular energy.
Current data suggest a nuanced role for creatine supplementation. It is a safe, effective tool for enhancing muscle strength and lean mass, though its benefits are largely contingent upon concurrent resistance training. Conversely, creatine does not function as a standalone treatment for bone density, and its direct effects on skeletal health remain preliminary. Consequently, its clinical value lies in its role as an ergogenic enhancer within a structured exercise framework.
What the Evidence Actually Shows
A 2026 systematic review focused on postmenopausal women (Naddafha et al., 2026), alongside a decade of pooled analyses, provides a clear framework for expectations. The evidence indicates modest but consistent benefits in specific areas, while highlighting significant limitations in others. Most current data involve postmenopausal cohorts; high-quality evidence specific to the perimenopausal transition remains emerging.
Muscle and Strength: A Small but Real Benefit
The strongest case for creatine lies in its impact on muscle. Meta-analyses and reviews demonstrate that creatine combined with resistance training leads to small but statistically reliable gains in lean body mass, typically between 0.4 and 1.4 kg, and improvements in both upper- and lower-body strength (Naddafha et al., 2026; Smith-Ryan et al., 2021; Forbes et al., 2021; Chilibeck et al., 2017). These gains are most evident with daily doses of at least 5g over interventions lasting 24 weeks or longer.
The primary biochemical mechanism is well-established: supplemental creatine increases intramuscular phosphocreatine stores, facilitating the rapid regeneration of ATP during high-intensity effort. It may additionally influence anabolic signaling pathways, although this mechanism is less firmly established. This allows for a slight increase in training volume and intensity, which translates to measurable adaptations over several months.
However, two clinical realities apply. First, creatine without resistance training shows minimal to no effect on muscle mass or strength in postmenopausal women; it functions as an ergogenic aid to exercise, not a replacement for it (Lobo et al., 2015). Second, a portion of the earliest increase in lean mass may reflect intracellular water rather than immediate contractile tissue growth, although this is easily overstated, and longer-term gains alongside resistance training reflect genuine adaptation (Desai et al., 2025).
Bone: Density No, Geometry Maybe
Rigorous randomised controlled trials indicate that creatine, whether used alone or with exercise, does not reliably increase bone mineral density (BMD) at clinically significant sites like the lumbar spine or femoral neck (Naddafha et al., 2026; Sales et al., 2020; Chilibeck et al., 2023; Forbes & Candow, 2018). Creatine is not an indicated treatment for osteoporosis.
A separate, more preliminary signal involves "bone geometry", structural properties such as cortical thickness and section modulus at the femur. Some trials suggest these geometric markers may improve when creatine is paired with resistance training (Chilibeck et al., 2015, 2023; Candow et al., 2025). Notably, these trials used higher, body-weight-based doses (approximately 0.1–0.14 g/kg/day, well above the 3–5 g/day typically used for muscle), so the standard dose should not be assumed to deliver bone effects. While better bone geometry could theoretically improve structural integrity, these findings are currently hypothesis-generating; no data yet confirm a reduction in fracture risk.
Consequently, the clinical foundation for bone health remains progressive resistance training, impact loading, and adequate intake of protein, calcium, and Vitamin D. Creatine’s most plausible benefit to bone is likely indirect: by improving muscle strength and balance, it may help prevent the falls that lead to fractures.
Safety
Creatine monohydrate has an extensive safety profile. In postmenopausal cohorts, trials lasting up to two years show adverse events comparable to placebo, with no evidence of impaired kidney function (Naddafha et al., 2026; Lobo et al., 2015; Kreider et al., 2025). As with any supplement, individuals with pre-existing renal disease or complex conditions should consult a healthcare provider.
Practical Use
Dosage: 3–5g daily of creatine monohydrate. Optimal muscle benefits are observed at ≥5g/day over longer durations (≥24 weeks).
Loading: Optional. 20g/day for 5–7 days reaches saturation faster but may cause transient water retention; consistent daily dosing reaches saturation in 3–4 weeks.
Timing: Daily consistency is the priority; specific timing around exercise is of secondary importance.
Selection: Use third-party tested Creatine monohydrate to ensure high impurity control.
Important Factor: Must be paired with resistance training. Without it, creatine provides minimal benefit to lean mass or strength.
What to Watch Next
The current landscape of clinical trial registries is revealing, not just for what is actively being studied, but for what is conspicuously missing. A search of ClinicalTrials.gov returned no ongoing trials evaluating creatine for both muscle and bone health specifically in postmenopausal women. The definitive, large-scale studies anchoring our current understanding have already been reported, meaning the baseline science is unlikely to shift anytime soon. Instead, the newest wave of research has shifted into adjacent territory.
A primary example is an ongoing randomised controlled trial pairing high-intensity resistance training with creatine in perimenopausal women (ClinicalTrials.gov, NCT07027800). This study aims directly at muscle outcomes during the transition window where high-quality data has historically been thinnest. While it is a trial worth tracking, it remains focused entirely on perimenopause and does not assess bone health.
This glaring data gap highlights the two critical questions that will shape the future of musculoskeletal longevity for women: Do geometric improvements prevent actual fractures? We know that pairing creatine with resistance training can alter structural markers like bone geometry. The real test is whether these scan-based changes translate into clinical outcomes that matter, fewer falls and fewer broken bones. Answering this requires long-term trials tracking hard fracture endpoints, which simply do not exist yet. What do female-specific protocols look like? The field needs to establish optimal dosing and timing strategies built specifically around female biology, rather than continually inheriting protocols extrapolated from male or younger athletic cohorts.
The most encouraging shift in modern sports science isn't a single breakthrough study; it is a fundamental change in methodology. Research is finally being designed for women, rather than trying to fit women into data built for men. As these new trials unfold and report their findings, we will update what we tell you accordingly.
Key Takeaways
Muscle/Strength: Modest, reliable benefits when combined with resistance training (Naddafha et al., 2026).
Bone Density: No reliable clinical effect on BMD at lumbar or femoral sites.
Bone Geometry: Emerging hypothesis for improved structural markers with training, but lacks clinical fracture data.
Safety: Highly safe and well-tolerated for long-term use in healthy women.
Synergy: Creatine is an enhancer of exercise stimulus and not a solution on its own.
The field is still young: A search of ClinicalTrials.gov returned no ongoing trials evaluating creatine for both muscle and bone health specifically in postmenopausal women, leaving fracture-related endpoints and optimal dosing as the open questions to watch.
Note: This article summarizes current evidence in postmenopausal and older women. It is intended as general education and is not a substitute for individual medical advice. Decisions about supplementation should account for personal health status and, where relevant, be discussed with a healthcare professional.
We all rise together,
Isabelle
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
More articles by Isabelle
Frequently asked questions
What does creatine actually do for women going through menopause?
Creatine helps your muscles produce energy more quickly during exercise. When paired with resistance training, it produces small but reliable gains in lean muscle mass and strength, typically an extra 0.4–1.4 kg of lean mass over six months or more. During menopause, when declining estrogen makes it harder to build and keep muscle, this extra boost from exercise can be meaningful.
Can I supplement creatine without going to the gym?
You can, and it will result in greater creatine amounts being stored in your muscles; however, please do remember that it works as an enhancer of exercise, not a replacement for it. This article has been written to focus on the topic of muscle growth and health as it relates to menopause, so we recommend that you think of creatine as helping you get a little more out of every session, rather than doing the work for you.
Will creatine protect my bones and prevent osteoporosis?
No, not directly. Creatine does not reliably increase bone mineral density at sites like the spine or hip, and it is not a treatment for osteoporosis. Some early research suggests it may improve the structural shape and thickness of bones when combined with resistance training, but this hasn't been shown to reduce fracture risk yet. For bone health, the foundations remain weight-bearing exercise, calcium, Vitamin D, and adequate protein.
Is creatine safe for women to supplement long-term?
Yes. Creatine monohydrate has a well-established safety record. Trials in postmenopausal women lasting up to two years show side effects comparable to a sugar pill, with no evidence of kidney harm in healthy individuals. If you have pre-existing kidney disease or complex health conditions, check with your doctor first.
How much should I supplement with, and when?
The standard dose is 3–5g of creatine monohydrate daily, with the best muscle benefits seen at 5g or more supplemented consistently for at least 24 weeks. Timing around exercise is less important than simply taking it every day. You can skip the "loading phase"... daily dosing reaches the same point within 3–4 weeks, just more gradually. Choose a third-party tested product to ensure good quality.
Will creatine make me look bloated or cause water weight gain?
Some people notice a small amount of water retention in the early weeks, particularly with a high loading dose. This is because creatine draws water into muscle cells. It's easy to overstate; at a standard daily dose without loading, the effect is modest, and longer-term gains from training reflect real muscle adaptation, not just water.
Does creatine interact with hormone therapy (HRT)?
Current research doesn't show interactions between creatine and hormone therapy, and many trials have included women using HRT. That said, studies specifically comparing the two together are limited. If you're on hormone therapy and considering creatine, it's worth discussing with your healthcare provider as part of your broader plan.
Further Reading and References
Candow D, et al. Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. J Clin Med, 2019.
Candow DG, et al. Creatine monohydrate supplementation for older adults and clinical populations. J Int Soc Sports Nutr, 2025.
Chen KH, et al. Nutritional supplementation combined with exercise for musculoskeletal health in women: a systematic review and meta-analysis. Int J Med Sci, 2026.
Chilibeck P, et al. Effects of creatine and resistance training on bone health in postmenopausal women. Med Sci Sports Exerc, 2015.
Chilibeck P, et al. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med, 2017.
Chilibeck P, et al. A 2-yr randomized controlled trial on creatine supplementation during exercise for postmenopausal bone health. Med Sci Sports Exerc, 2023.
De Guingand D, et al. Risk of adverse outcomes in females taking oral creatine monohydrate: a systematic review and meta-analysis. Nutrients, 2020.
Desai I, et al. The effect of creatine supplementation on lean body mass with and without resistance training. Nutrients, 2025.
Forbes SC, et al. Creatine supplementation during resistance training does not lead to greater bone mineral density in older humans: a brief meta-analysis. Front Nutr, 2018.
Forbes SC, et al. Meta-analysis examining the importance of creatine ingestion strategies on lean tissue mass and strength in older adults. Nutrients, 2021.
Gualano B, et al. Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial. Exp Gerontol, 2014.
Kreider R, et al. Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports. J Int Soc Sports Nutr, 2025.
Lobo D, et al. Effects of long-term low-dose dietary creatine supplementation in older women. Exp Gerontol, 2015.
Naddafha S, et al. Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. J Int Soc Sports Nutr, 2026.
Sales L, et al. Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial. J Gerontol A Biol Sci Med Sci, 2020.
Santos EEP, et al. Efficacy of creatine supplementation combined with resistance training on muscle strength and muscle mass in older females: a systematic review and meta-analysis. Nutrients, 2021.
Smith‑Ryan A, et al. Creatine supplementation in women’s health: a lifespan perspective. Nutrients, 2021.
Walter F, et al. Analysis of the additive effects of nutritional strategies in strength training interventions on body composition, muscle strength and bone mineral density in postmenopausal women: a systematic review. Sports Med Open, 2026.
Can creatine really help counteract the muscle and bone changes that happen during menopause? Isabelle Statovci dives into what the latest clinical evidence reveals about its true benefits, limitations, and how to use it safely.